Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silverio Perrotta

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
British Journal of Haematology|May 21, 2019
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literatureImmacolata Tartaglione, Renzo Manara, Martina Caiazza, et al.
Haematologica|March 4, 2014
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-HematologyDaniela De Rocco, Roberta Bottega, Enrico Cappelli, et al.
British Journal of Haematology|March 6, 2019
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance studyImmacolata Tartaglione, Camilla Russo, Andrea Elefante, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohortImmacolata Tartaglione, Crawford Strunk, Charles Antwi-Boasiako, et al.
Haematologica|January 23, 2025
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide studyBarbara Gianesin, Frédéric B Piel, Khaled M Musallam, et al.
Orphanet Journal of Rare Diseases|August 6, 2021
Auditory cortex hypoperfusion: a metabolic hallmark in Beta ThalassemiaRenzo Manara, Sara Ponticorvo, Silverio Perrotta, et al.
Haematologica|January 7, 2021
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohortMaddalena Casale, Gian Luca Forni, Elena Cassinerio, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Tumori|July 1, 2017
Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over ItalyMatteo Silva, Marco Chisari, Stefano Signoroni, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
British Journal of Haematology|May 21, 2019
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literatureImmacolata Tartaglione, Renzo Manara, Martina Caiazza, et al.
Haematologica|March 4, 2014
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-HematologyDaniela De Rocco, Roberta Bottega, Enrico Cappelli, et al.
British Journal of Haematology|March 6, 2019
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance studyImmacolata Tartaglione, Camilla Russo, Andrea Elefante, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohortImmacolata Tartaglione, Crawford Strunk, Charles Antwi-Boasiako, et al.
Haematologica|January 23, 2025
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide studyBarbara Gianesin, Frédéric B Piel, Khaled M Musallam, et al.
Orphanet Journal of Rare Diseases|August 6, 2021
Auditory cortex hypoperfusion: a metabolic hallmark in Beta ThalassemiaRenzo Manara, Sara Ponticorvo, Silverio Perrotta, et al.
Haematologica|January 7, 2021
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohortMaddalena Casale, Gian Luca Forni, Elena Cassinerio, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Tumori|July 1, 2017
Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over ItalyMatteo Silva, Marco Chisari, Stefano Signoroni, et al.
Pageof 20